Wes Streeting said the virus places the health service under 'huge strain' every winter and costs taxpayers around ...

In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US ...

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing ...

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

A woman is in critical condition after an interstate crash, according to. The crash happened just after 1:30 p.m., at the on ramp from London Bridge to 264 West. State police said the elderly woman ...

Experts believe the vaccine could stop people developing the bug, which is linked to around 12,000 hospital admissions in the UK every year. | ITV National News ...

On Monday, Moderna Inc (MRNA) stock saw a decline, ending the day at $53.8 which represents a decrease of $-0.30 or -0.55% from the prior close of $54.1. The stock opened at $53.82 and touched a low ...

Roivant's high valuation is justified, with a strong cash position, promising drug pipeline, and strategic partnerships ...